Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. |
Mylan Pharmaceuticals Inc. |
1:2022cv00061 |
August 2, 2022 |
US District Court for the Northern District of West Virginia |
Thomas S Kleeh |
Patent |
28 U.S.C. § 1338 Patent Infringement |
Plaintiff |
Docket Report
This docket was last retrieved on January 31, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 78 RESPONSE by Regeneron Pharmaceuticals, Inc. to #77 Other Document. (Attachments: #1 Proposed Order Proposed Scheduling Order)(Ruby, Steven) |
Filing 77 Other Document Defendant Mylan Pharmaceuticals Inc.s Post-Hearing Supplement filed by Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
Filing 76 MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Status Conference held on 9/28/2022. (Court Reporter Rachel Kocher) (dk) |
Filing 75 REPORT of Rule 26(f) Planning Meeting. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B)(Ruby, Steven) |
Filing 74 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. for Plaintiff's Rule 26(a) Initial Disclosures. (Ruby, Steven) |
Filing 73 ORDER SCHEDULING STATUS CONFERENCE for 9/28/2022 02:30 PM, via Zoom videoconferencing, before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 9/20/2022. (dk) |
Filing 72 ORDER granting #68 Motion of Katie A. Body for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/20/2022. (dk) |
Filing 71 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. Regeneron's Second Requests for Production of Documents and things to Mylan Pharmaceuticals Inc. (Ruby, Steven) |
Filing 70 Regeneron Pharmaceuticals Inc.'s ANSWER to #47 Answer to Complaint, Counterclaim by Regeneron Pharmaceuticals, Inc..(Ruby, Steven) |
Filing 69 Pro Hac Vice Filing fee: $ 200.00, receipt number WVNC003515 for Attorney K. Boda. (jmm) |
Filing 68 MOTION for Leave to Appear Pro Hac Vice (Katie A. Boda) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 67 ORDER granting #56 Motion of Abraham J. Varon for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/13/2022. (dk) |
Filing 66 PHV Filing fee for A. Varon in the amount of $ 200.00. Receipt number WVNC03508. (jb) |
Filing 65 ORDER granting #52 Motion for Leave to Appear Pro Hac Vice (Jeffrey A. Marx) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 64 ORDER granting #51 Motion for Leave to Appear Pro Hac Vice (Thomas H. Ehrich) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 63 ORDER granting #50 Motion for Leave to Appear Pro Hac Vice (Steven J. Birkos) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 62 ORDER granting #49 Motion for Leave to Appear Pro Hac Vice (Lawrence Scott Beall) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 61 ORDER granting #46 Motion for Leave to Appear Pro Hac Vice (Heinz J. Salmen) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 60 ORDER granting #45 Motion for Leave to Appear Pro Hac Vice (Eric R. Hunt) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 59 ORDER granting #44 Motion for Leave to Appear Pro Hac Vice (Neil B. McLaughlin) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 58 ORDER granting #43 Motion for Leave to Appear Pro Hac Vice (William A. Rakoczy) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 57 ORDER granting #42 Motion for Leave to Appear Pro Hac Vice (Lauren M. Lesko) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 9/6/2022. (jb) |
Filing 56 MOTION for Leave to Appear Pro Hac Vice (Abraham J. Varon) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 55 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. First Requests for Production to Mylan Pharmaceuticals Inc.. (Pogue, David) |
Filing 54 CERTIFICATE OF SERVICE by Regeneron Pharmaceuticals, Inc. First Set of Interrogatories to Mylan Pharmaceuticals In.c. (Pogue, David) |
Filing 53 Pro Hac Vice Filing fee in the amount of $ 800.00 for attorneys J. Marx, T. Ehrich, S. Birkos and L. Beall. Receipt number WVNC003502. (jb) |
Filing 52 MOTION for Leave to Appear Pro Hac Vice (Jeffrey A. Marx) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 51 MOTION for Leave to Appear Pro Hac Vice (Thomas H. Ehrich) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 50 MOTION for Leave to Appear Pro Hac Vice (Steven J. Birkos) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 49 MOTION for Leave to Appear Pro Hac Vice (Lawrence Scott Beall) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William) |
Filing 48 Pro Hac Vice Filing fee in the amount of $ 1,000.00 for L. Lesko, W. Rakoczy, N. McLaughlin, E. Hunt & H. Salmen. Receipt number WVNC003501. (jb) |
Filing 47 ANSWER to #1 Complaint,,,,, , COUNTERCLAIM against Regeneron Pharmaceuticals, Inc. by Mylan Pharmaceuticals Inc..(O'Brien, William) |
Filing 46 MOTION for Leave to Appear Pro Hac Vice (Heinz J. Salmen) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Copland, Gordon) |
Filing 45 MOTION for Leave to Appear Pro Hac Vice (Eric R. Hunt) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Copland, Gordon) |
Filing 44 MOTION for Leave to Appear Pro Hac Vice (Neil B. McLaughlin) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Copland, Gordon) |
Filing 43 MOTION for Leave to Appear Pro Hac Vice (William A. Rakoczy) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Copland, Gordon) |
Filing 42 MOTION for Leave to Appear Pro Hac Vice (Lauren M. Lesko) by Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Copland, Gordon) |
Filing 41 REPLY to Response to Motion re #7 MOTION for Hearing - Requesting Expedited Status Conference filed by Regeneron Pharmaceuticals, Inc.. (Pogue, David) |
Filing 40 ORDER granting #15 Motion of Shaun P. Mahaffy for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 39 ORDER granting #16 Motion of Thomas S. Fletcher for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 38 ORDER granting #17 Motion of Teagan J. Gregory for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 37 ORDER granting #21 Motion of Petra Scamborova for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 36 ORDER granting #22 Motion of Larry Coury for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 35 ORDER granting #23 Motion of James Evans for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 34 ORDER granting #10 Motion of Andrew V. Trask for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 33 ORDER granting #11 Motion of David I. Berl for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 32 ORDER granting #12 Motion of Ellen E. Oberwetter for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 31 ORDER granting #13 Motion of Kathryn S. Kayali for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 30 ORDER granting #14 Motion of Nicholas W. Jordan for Leave to Appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 29 ORDER granting #9 Motion of Adam Pan for leave to appear Pro Hac Vice on behalf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 28 ORDER granting #8 Motion of Arthur J. Argall, III for leave to appear Pro Hac Vice on behaf of Regeneron Pharmaceuticals, Inc. Signed by Chief District Judge Thomas S Kleeh on 8/22/2022. (dk) |
Filing 27 VERIFICATION OF ATTORNEY ADMISSION issued to Attorneys W. Rakoczy, H. Salmen, E. Hunt, N. McLaughlin, and L. Lesko. (dk) |
Filing 26 RESPONSE in Opposition re #7 MOTION for Hearing - Requesting Expedited Status Conference filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Filing 25 Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc... (O'Brien, William) |
Filing 24 Filing fee for Pro Hac Vice admission of J. Evans, L. Coury and P. Scamborova in the amount of $ 600.00. Receipt number WVNC003495. (jb) |
Filing 23 Application for Admission Pro Hac Vice for James Evans Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/18/2022 (dk). |
Filing 22 Application for Admission Pro Hac Vice of Larry Coury Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/18/2022 (dk). |
Filing 21 Application for Admission Pro Hac Vice of Petra Scamborova Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/18/2022 (dk). |
Filing 20 Pro Hac Vice Filing fee for T. Gregory, T. Fletcher, S. Mahaffy, N. Jordan, K. Kayali, E. Oberwetter, D. Berl, A. Trask, A. Pan and A. Argall: $2,000.00. Receipt number WVNC003489. (jb) |
Filing 19 FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 9/9/2022. Rule 26 Meeting Report due by 9/23/2022. Discovery due by 10/10/2022. Signed by Chief District Judge Thomas S Kleeh on 8/10/2022. (dk) |
Filing 18 NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) |
Filing 17 Application for Admission Pro Hac Vice of Teagan J. Gregory Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make pending motion on 8/10/2022 (dk). |
Filing 16 Application for Admission Pro Hac Vice of Thomas S. Fletcher Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make pending motion on 8/10/2022 (dk). |
Filing 15 Application for Admission Pro Hac Vice of Shaun P. Mahaffy Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 14 Application for Admission Pro Hac Vice of Nicholas W. Jordan Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 13 Application for Admission Pro Hac Vice of Kathryn S. Kayali Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 12 Application for Admission Pro Hac Vice of Ellen E. Oberwetter Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 11 Application for Admission Pro Hac Vice of David I. Berl Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Attachment B, #3 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 10 Application for Admission Pro Hac Vice of Andrew V. Trask Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 9 Application for Admission Pro Hac Vice of Adam Pan Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 8 Application for Admission Pro Hac Vice of Arthur J. Argall III Other Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: #1 Attachment A, #2 Exhibit WVSB Receipt)(Ruby, Steven) Modified to make a pending motion on 8/10/2022 (dk). |
Filing 7 MOTION for Hearing - Requesting Expedited Status Conference by Regeneron Pharmaceuticals, Inc.. (Ruby, Steven) |
Filing 6 SUMMONS Returned Executed as to Mylan Pharmaceuticals Inc. served on 8/4/2022. (Pogue, David) |
Filing 5 Corporate Disclosure Statement by Regeneron Pharmaceuticals, Inc.. (Pogue, David) |
Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (dk) |
Filing 2 VERIFICATION OF ATTORNEY ADMISSION issued to D. Berl, E. Oberwetter, T. Fletcher, A. Trask, T. Gregory, S. Mahaffy, K. Kayali, A. Argall, A. Pan, and N. Jordan. (dk) |
Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., filed by Regeneron Pharmaceuticals, Inc. Filing Fee $402. Receipt #AWVNDC-3522822. (Attachments: #1 Exhibit 1 - US Patent 7,070,959 B1, #2 Exhibit 2 - US Patent 9,222,106 B2, #3 Exhibit 3 - US Patent 9,254,338 B2, #4 Exhibit 4 - US Patent 9,669,069 B2, #5 Exhibit 5 - US Patent 9,816,110 B2, #6 Exhibit 6 - US Patent 10,130,681 B2, #7 Exhibit 7 - US Patent 10,406,226 B2, #8 Exhibit 8 - US Patent 10,415,055 B2, #9 Exhibit 9 - US Patent 10,464,992 B2, #10 Exhibit 10 - US Patent 10,669,594 B2, #11 Exhibit 11 - US Patent 10,857,205 B2, #12 Exhibit 12 - US Patent 10,888,601 B2, #13 Exhibit 13 - US Patent 10,927,342 B2, #14 Exhibit 14 - US Patent 10,973,879 B2, #15 Exhibit 15 - US Patent 11,053,280 B2, #16 Exhibit 16 - US Patent 11,066,458 B2, #17 Exhibit 17 - US Patent 11,084,865 B2, #18 Exhibit 18 - US Patent 11,104,715 B2, #19 Exhibit 19 - US Patent 11,174,283 B2, #20 Exhibit 20 - US Patent 11,186,625 B2, #21 Exhibit 21 - US Patent 11,253,572 B2, #22 Exhibit 22 - US Patent 11,299,532 B2, #23 Exhibit 23 - US Patent 11,306,135 B2, #24 Exhibit 24 - US Patent 11,332,771 B2, #25 Civil Cover Sheet, #26 Proposed AO120 Form)(dk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Search for this case: Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. | |
---|---|
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
Plaintiff: Regeneron Pharmaceuticals, Inc. | |
Represented By: | Adam Pan |
Represented By: | Andrew V. Trask |
Represented By: | Arthur J. Argall, III |
Represented By: | David I. Berl |
Represented By: | David R. Pogue |
Represented By: | Ellen E. Oberwetter |
Represented By: | Kathryn S. Kayali |
Represented By: | Nicholas Jordan |
Represented By: | Shaun P. Mahaffy |
Represented By: | Steven Robert Ruby |
Represented By: | Teagan J. Gregory |
Represented By: | Thomas S. Fletcher |
Represented By: | James Evans |
Represented By: | Larry Coury |
Represented By: | Petra Scamborova |
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Defendant: Mylan Pharmaceuticals Inc. | |
Represented By: | Abraham J. Varon |
Represented By: | Eric R. Hunt |
Represented By: | Gordon H. Copland |
Represented By: | Heinz J. Salmen |
Represented By: | Jeffery A. Marx |
Represented By: | Katie A. Boda |
Represented By: | Lauren M. Lesko |
Represented By: | Lawrence Scott Beall |
Represented By: | Neil B. McLaughlin |
Represented By: | Steven J. Birkos |
Represented By: | Thomas H. Ehrich |
Represented By: | William J O'Brien |
Represented By: | William A. Rakoczy |
Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.